Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

Drug Office - Pharmaceutical Trade Homepage

Frontiers Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations

Drug Office - Pharmaceutical Trade Homepage

Pharmaceutical Service

Drug Office - Other safety alerts

Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics - ScienceDirect

Pseudoephedrine safety review due to rare brain risk

藥物辦公室- 消費者主頁

Frontiers Management and Clinical Outcome of Posterior Reversible Encephalopathy Syndrome in Pediatric Oncologic/Hematologic Diseases: A PRES Subgroup Analysis With a Large Sample Size

藥物辦公室– 藥劑業界主頁

Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation

PDF) Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study

Clinical relevance of reversible cerebral vasoconstriction syndrome in pregnant women with posterior reversible encephalopathy syndrome: review of case reports in Japan

HSA-Eligible Expenses in 2023 and 2024 that Qualify for

The best FSA- and HSA-eligible beauty products to snag before year's end

19 Baby Items You Can Buy With Pre-Tax Dollars in 2024

FSA-Eligible Massage Chair HSA-Approved Massage Chair

The best HSA and FSA eligible products to buy